Cadila Healthcare Share Price Rallies After Receiving FDA Boost – Shares of the drugmaker rose as much as 3.8 percent to Rs 363.10.
The pharmaceutical company received a green signal from the U.S drug regulator Clindamycin Phosphate Topical Solution, used to treat acne, according to its stock exchange filing.
Gold Silver Reports (GSR) – Stocks To Watch: Bank Of Baroda, Cadila Healthcare, Sun Pharma, Tech Mahindra — The Singapore-traded SGX Nifty, an early indicator of NSE Nifty 50 Index’s performance in India, fluctuated between gains and losses to trade at 10,512 as of 7:30 a.m. Asian stocks opened lower after the cancellation of the U.S.-North Korea summit, which sparked a move to safe-haven assets.